What Zymergen Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Peterson Sandra E | Director | Oct 19 | Disposition to Issuer · D | −119,119 | — | — | 0 |
| Gorjanc Christine Marie | Director | Oct 19 | Disposition to Issuer · D | −50,000 | — | — | 0 |
| Flatley Jay T | Chairman and Acting CEO | Oct 19 | Disposition to Issuer · D | −144,789 | — | — | 0 |
| Chu Steven | Director | Oct 19 | Disposition to Issuer · D | −50,000 | — | — | 0 |
| Svf Excaliber (Cayman) Ltd | 10% owner | Oct 19 | Other Transaction · J | −26,614,219 | — | — | 0 |
| Murdoch Travis | Director | Oct 19 | Disposition to Issuer · D | −79,697 | — | — | 0 |
| Ocko Matthew | Director | Oct 19 | Disposition to Issuer · D | −4,917,734 | — | — | 0 |
| Ocko Matthew | Director | Oct 19 | Disposition to Issuer · D | −2,448,901 | — | — | 0 |
| Singh Enakshi | Chief Financial Officer | Oct 19 | Disposition to Issuer · D | −462,241 | — | — | 0 |
| Serber Zachariah | Director | Oct 19 | Disposition to Issuer · D | −40,000 | — | — | 0 |
| Serber Zachariah | Director | Oct 19 | Disposition to Issuer · D | −40,000 | — | — | 0 |
| Serber Zachariah | Director | Oct 19 | Disposition to Issuer · D | −2,551,685 | — | — | 0 |
| Singh Enakshi | Chief Financial Officer | Oct 03 | Open-market sale · S | −3,786 | $2.80 | −$10.6K | 462,241 |
| Serber Zachariah | Chief Science Officer | Sep 02 | Open-market sale · S | −3,268 | $2.21 | −$7.22K | 2,551,685 |
| Singh Enakshi | Chief Financial Officer | Sep 02 | Open-market sale · S | −3,928 | $2.21 | −$8.68K | 466,027 |
| Kim Mina | Chief Legal Officer | Sep 02 | Open-market sale · S | −3,410 | $2.21 | −$7.54K | 298,427 |
| Singh Enakshi | Chief Financial Officer | Aug 30 | Open-market sale · S | −15,365 | $2.27 | −$34.9K | 469,955 |
| Singh Enakshi | Chief Financial Officer | Aug 12 | Grant / award · A | +8,320 | — | — | 485,320 |
| Serber Zachariah | Chief Science Officer | Aug 11 | Disclosed 10b5-1 sale · S | −5,435 | $3.91 | −$21.3K | 2,554,953 |
| Kim Mina | Chief Legal Officer | Aug 02 | Open-market sale · S | −3,094 | $2.61 | −$8.08K | 301,837 |
Loading...